TAMBE Japan Post-Marketing Surveillance

ConditionsThoracoabdominal Aortic Aneurysm Pararenal Aortic Aneurysm

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorW.L.Gore & Associates

About this trial

To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.

Eligibility criteria

Qualifiers

Patients who were attempted to implant the AC

Thoracoabdominal aortic aneurysm

Pararenal abdominal aortic aneurysm

Disqualifiers

N/A

Trial design

Treatments tested in this trial

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

Treatment groups

100 Participants

are divided into 1 treatment group

Sponsors and collaborators

W.L.Gore & Associates

Lead sponsor

CMIC Co, Ltd. Japan

Collaborator

Source ClinicalTrials.gov